Luca Santarelli, VectivBio CEO
MPM-backed Werewolf, Merck-partnered Artiva make quick IPO flip while Luca Santarelli's biotech raises $127.5M
The jump from crossover rounds to biotech IPO is quicker than ever.
Just weeks after unveiling Series B rounds, MPM-backed Werewolf and Merck-partnered Artiva are …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.